Charlotte Brennand

Charlotte Brennand

Director of Operational Excellence

Charlotte Brennand joined ITBMed in April 2021. She brings to ITBMed more than 17 of years of experience in global trial management across all phases, including Observational Studies and Registries. Most recently, Charlotte served as an Associate Director, Clinical Operations at Alexion Pharmaceuticals. Previously, Charlotte has held positions in Clinical Operations at Retrophin (now Travere Therapeutics), Takeda Pharmaceuticals, Genzyme Corporation (now a division of Sanofi) and Boston University School of Medicine. Charlotte holds a Master’s degree in Public Health from University of Massachusetts, Amherst and Bachelor of Science from Ithaca College, New York.